Clinical studies implementing glutamate neurotransmission in mood disorders. - Wikidata - wikimedia - TriplyDB

Clinical studies implementing glutamate neurotransmission in mood disorders.

Clinical studies implementing glutamate neurotransmission in mood disorders.

http://www.wikidata.org/entity/Q30886466

about

The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents Stress as a one-armed bandit: Differential effects of stress paradigms on the morphology, neurochemistry and behavior in the rodent amygdala.New approaches to antidepressant drug discovery: beyond monoamines Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs A genome-wide association study of antidepressant response in Koreans Bipolar disorder: candidate drug targets.An update of the classical and novel methods used for measuring fast neurotransmitters during normal and brain altered function Advances in the treatment of anxiety: targeting glutamate.Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.Prefrontal cortex glutamate correlates with mental perspective-taking.Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.Glutamatergic and GABAergic metabolism in mouse brain under chronic nicotine exposure: implications for addiction Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action.Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole Novel drugs and therapeutic targets for severe mood disorders.Disturbance of the glutamatergic system in mood disorders.Hippocampal interneurons in bipolar disorder.Estrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons.Proton magnetic resonance spectroscopy in depression Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.GABA and glutamate systems as therapeutic targets in depression and mood disorders.Glutamate modulators as novel interventions for mood disorders.The same antidepressant elicits contrasting patterns of synaptic changes in the amygdala vs hippocampus Candidate genes for antidepressant response to selective serotonin reuptake inhibitors Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice Gliogenesis and glial pathology in depression.From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.Early intervention in bipolar disorder, part II: therapeutics Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors.Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms.GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - A (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy Improving antidepressant drugs: update on recently patented compounds.Glutamate and choline levels predict individual differences in reading ability in emergent readers.Investigational NMDA receptor modulators for depression.

P2860

Q24613593-293929E7-21F4-49B5-8C92-A03E80354AB8 Q24656267-F3540E06-5E65-40C0-B276-0C94C16DE588 Q26769043-D37E586C-F276-48C7-B508-257D14A5E0FE Q28293089-178EE143-4383-49C3-84C2-317B70DCDA6A Q28305100-CABD1980-C1DC-4D04-AC22-83B58D2A67B6 Q28597255-F0F87920-35D8-47AE-8C8F-EC7F386C8647 Q28751133-4F75C866-23F9-4FF2-91D6-4763020D84A4 Q30410156-66000BC5-E275-461B-96E4-BF682C93EB1B Q30457479-D58CAC34-974D-4252-9C03-386B14686220 Q31032734-54380BAA-94CB-4028-ABEA-C89BDBF05F7C Q33389974-95BBE792-6658-4060-A8E0-D6F90D5FE669 Q33390364-EB553293-6F25-417E-B7E4-9E658019892C Q33553152-C3065E56-5573-4819-86CA-6EC6DE7331BF Q34359105-D1EA0405-5CEE-4197-927D-DA51188D9FC0 Q34522617-1B0A37AD-8181-4677-9BD0-57252CA0F075 Q34661581-19FBC758-1C28-4A27-84F0-2C4272BE062B Q34732759-734719B8-238E-4326-8700-7A1927245CFC Q35149888-4B231C57-240C-4F89-9F98-0B563D19DE53 Q35400508-72A8D51B-0497-46DB-BE1F-61F36DC1FED9 Q35539953-23FCF7DC-B8A1-4706-922C-6C8DAB8844B8 Q35702054-2222C21F-7EF9-4F57-8BCE-AF0249D8C21E Q35747079-8A091193-3970-4037-81FA-24D1BAB9CA4F Q36066308-090E997C-B122-4547-AD1E-345489033403 Q36285982-F493BB33-40A9-4D46-AECB-0682CA4D8FA9 Q36323561-DDA17334-F286-4D84-A481-97419B392424 Q36718053-B3030626-7BA5-4AB1-9467-BB98DB06A4EE Q36788384-CCB67FA0-5688-4B7D-8C49-36BDB7882135 Q36825936-908FF97D-718F-4957-83E8-AA1A11E18179 Q36944201-5CE29110-E4AC-4CCF-9BAD-94A035E6CC39 Q36960864-BC63CF82-CB7B-4538-AF2D-1D25D8342968 Q37071007-3BDAFDC0-1111-4A45-8F73-27B1561C96A6 Q37248070-B32855DD-5D85-46FA-8898-CABB7477FCCB Q37259435-6443FEC4-73BC-43EB-B497-AD57305997CF Q37307000-4F8210D9-ADDA-4DE6-868B-AF381E504ECA Q37368290-2F422971-7E5A-4226-BC32-5ACE7E7EE4E4 Q37408446-100FBBDE-2CC5-49CB-8899-9B9E18B37297 Q37456927-30BE59C7-1C72-4428-B021-D79242368553 Q37497379-A245AEDB-3493-4A6A-BD32-739F0E1FE3E6 Q37633638-861244E1-D388-44B8-9D72-2C4550CC450B Q37957965-511295CD-F071-4FF3-BC3A-58EE7E580D65

P2860

Clinical studies implementing glutamate neurotransmission in mood disorders.

http://www.wikidata.org/entity/Q30886466

description

2003 nî lūn-bûn

@nan

2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Clinical studies implementing glutamate neurotransmission in mood disorders.

@ast

Clinical studies implementing glutamate neurotransmission in mood disorders.

@en

type

label

Clinical studies implementing glutamate neurotransmission in mood disorders.

@ast

Clinical studies implementing glutamate neurotransmission in mood disorders.

@en

prefLabel

Clinical studies implementing glutamate neurotransmission in mood disorders.

@ast

Clinical studies implementing glutamate neurotransmission in mood disorders.

@en

P1433

Q30886466-D238F7B0-EE4C-4A43-98D9-6E15A23C529B

P1476

Q30886466-92843123-FC0B-4CCF-8291-38A4E8894A63

P2093

Q30886466-1CF91C6B-8F2B-4CF6-AC22-8AF94BA4ADBF

Q30886466-AE3A2087-C2CD-4960-891C-221993E7ECFB

Q30886466-EB04F7A9-2EDC-4192-95B7-8D4F71A3D732

Q30886466-F1AB04D7-39E6-4B43-9D9C-72884DC6D89F

P2860

Q30886466-098562DF-5E3B-46B8-B10B-62254DCE0C0B

Q30886466-50635CBE-B61E-4ED0-B37A-97C2B5EA0EAB

Q30886466-60DE2CEC-83DD-43DE-9FDF-526484DBE84A

Q30886466-7BDE6373-6465-429B-8F81-E807DDCD6DA2

Q30886466-8A545F08-CA83-4D54-AA57-DD71DCC44B50

Q30886466-B251C7E3-718D-419E-95CE-310B3CD98DF2

Q30886466-D87150BB-5C88-4C64-ACAF-F16B8CBC8008

Q30886466-EE24E407-A699-45D7-B387-0C4FD2FA5241

P304

Q30886466-CC76D729-6A85-4685-AC49-DF0651DE68F9

P31

Q30886466-607F2CE9-952D-4B64-8384-FBFB1F06D101

Q30886466-87a832df-f4bc-4f80-b886-e06243b81778

P356

Q30886466-AB895EB7-9A71-4E1A-A604-A5535628CAD1

P407

Q30886466-4EFB3D40-CF5C-4FD7-86CA-DCED904ED1EB

P478

Q30886466-8683A143-75A5-4ADA-AA75-3569DEB4B479

P577

Q30886466-FF207495-8A3A-40AC-AD0D-9326862A30BB

P5875

Q30886466-736D7482-7B94-47A8-BA2E-F118CEB97C28

P698

Q30886466-E77861B7-9AE1-4F45-B8C9-1BD3FFAE02E9

P356

ANNALS.1300.018

P1433

Annals of the New York Academy of Sciences

P1476

Clinical studies implementing glutamate neurotransmission in mood disorders.

@en

P2093

Douglas L Rothman

http://www.w3.org/2001/XMLSchema#string

Gerard Sanacora

http://www.w3.org/2001/XMLSchema#string

Graeme Mason

http://www.w3.org/2001/XMLSchema#string

John H Krystal

http://www.w3.org/2001/XMLSchema#string

P2860

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

Impairment of GABAergic transmission in depression: new insights from neuroimaging studies.

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5-HT2 binding site changes.

Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor.

Plasma and platelet excitatory amino acids in psychiatric disorders.

P304

292-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1300.018

http://www.w3.org/2001/XMLSchema#string

P407

P478

1003

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5566148

http://www.w3.org/2001/XMLSchema#string

P698

14684453

http://www.w3.org/2001/XMLSchema#string